ImmusanT scientists are hoping to provide a better solution for people with this disease. They are testing a treatment known as Nexvax2 that selectively modifies the immune response to gluten and improves tolerability to gluten.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,